NPCE logo

NPCE NeuroPace, Inc.

NASDAQ · Medical - Devices · Healthcare

$8.22
+0.02 (+0.24%)

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable an…

Market Cap: $283.19Mwww.neuropace.com

Price

No data yet.

Social Signal Score

38
5d
28
2 mentions
—
30d
37
3 mentions
—
60d
37
3 mentions
—
90d
49
6 mentions
—
news: 6

Analyst Ratings

10 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 1Sell 0Strong Sell 0
Avg price target$15.67+90.6%
Low $12Median $14High $21
Current Consensus

Revenue

$23.10M+131.62%
$7.64M$14.21M$20.78M$27.35M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-0.77
$-0.81–$-0.72
5 analysts
FY2026
$-0.58
$-0.66–$-0.54
5 analysts
FY2027
$-0.56
$-0.63–$-0.51
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Joel D. Becker
Sector
Healthcare
Industry
Medical - Devices
Employees
216
Beta
1.93
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-4.94
www.neuropace.com